Literature DB >> 22298608

Pulmonary vascular responses to exercise: a haemodynamic observation.

R Saggar, G D Lewis, D M Systrom, H C Champion, R Naeije, R Saggar.   

Abstract

Mesh：

Year:  2012        PMID： 22298608     DOI： 10.1183/09031936.00166211

Source DB:  PubMed          Journal:  Eur Respir J        ISSN： 0903-1936            Impact factor:   16.671


× No keyword cloud information.
  8 in total

1.  Exercise-induced pulmonary artery hypertension in a patient with compensated cardiac disease: hemodynamic and functional response to sildenafil therapy.

Authors:  Lazaros Nikolaidis; Nabeel Memon; Brian O'Murchu
Journal:  Tex Heart Inst J       Date:  2015-02-01

Review 2.  Exercise-induced pulmonary hypertension: physiological basis and methodological concerns.

Authors:  Robert Naeije; Rebecca Vanderpool; Bishnu P Dhakal; Rajeev Saggar; Rajan Saggar; Jean-Luc Vachiery; Gregory D Lewis
Journal:  Am J Respir Crit Care Med       Date:  2013-01-24       Impact factor: 21.405

3.  Metabolic Profiling of Right Ventricular-Pulmonary Vascular Function Reveals Circulating Biomarkers of Pulmonary Hypertension.

Authors:  Gregory D Lewis; Debby Ngo; Anna R Hemnes; Laurie Farrell; Carly Domos; Paul P Pappagianopoulos; Bishnu P Dhakal; Amanda Souza; Xu Shi; Meredith E Pugh; Arkadi Beloiartsev; Sumita Sinha; Clary B Clish; Robert E Gerszten
Journal:  J Am Coll Cardiol       Date:  2016-01-19       Impact factor: 24.094

4.  Pulmonary hemodynamic profile in chronic obstructive pulmonary disease.

Authors:  Karina Portillo; Yolanda Torralba; Isabel Blanco; Felip Burgos; Roberto Rodriguez-Roisin; Jose Rios; Josep Roca; Joan A Barberà
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2015-07-14

5.  Impairment of pulmonary vascular reserve and right ventricular systolic reserve in pulmonary arterial hypertension.

Authors:  Enric Domingo; Juan C Grignola; Rio Aguilar; Christian Arredondo; Nadia Bouteldja; Manuel López Messeguer; Antonio Roman
Journal:  BMC Pulm Med       Date:  2014-04-24       Impact factor: 3.317

6.  Potential benefit of bosentan therapy in borderline or less severe pulmonary hypertension secondary to idiopathic pulmonary fibrosis-an interim analysis of results from a prospective, single-center, randomized, parallel-group study.

Authors:  Yosuke Tanaka; Mitsunori Hino; Akihiko Gemma
Journal:  BMC Pulm Med       Date:  2017-12-13       Impact factor: 3.317

7.  Exercise capacity in COPD patients with exercise-induced pulmonary hypertension.

Authors:  Ingunn Skjørten; Janne Mykland Hilde; Morten Nissen Melsom; Jonny Hisdal; Viggo Hansteen; Kjetil Steine; Sjur Humerfelt
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2018-10-31

Review 8.  Exercise echocardiography for the assessment of pulmonary hypertension in systemic sclerosis: a systematic review.

Authors:  Rui Baptista; Sara Serra; Rui Martins; Rogério Teixeira; Graça Castro; Maria João Salvador; José António Pereira da Silva; Lèlita Santos; Pedro Monteiro; Mariano Pêgo
Journal:  Arthritis Res Ther       Date:  2016-07-02       Impact factor: 5.156
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.